USPTO 2015–2025 USPTO PatentsView US Corporation

Activbody, Inc.

USPTO PatentsView assignee record - 10 granted patents across 10 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Activbody ranks #25,647 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 10 technology areas.

#25,647
of 49,997 US assignees by volume
33rd percentile
by Innovation Score (30.1/100)
17.7
avg claims per patent
-75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25647 · US Corporation #25,647 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #25,647/49,997
  • PHOTO-FINISH Acessa Health
  • CPC-FOCUS A61B · 10 areas
  • INNOV-THIN 30.1/100
  • CLAIMS-RICH 17.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -75% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Acessa Health Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Activbody’s 30.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Activbody

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Activbody's Innovation Score is 30.1/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Activbody?

Each dot is one of Activbody’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Activbody’s own 17.7 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Activbody vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 9.99.91010.1 0510152025 Granted patents (volume) Avg claims / patent Acessa Health Inc. - 10, 18.7Acessa HealthAcme Furniture Industry, Inc. - 10, 1Acme Furniture In…ACR Electronics, Inc. - 10, 6.1ACRActimed Therapeutics Limited - 10, 14.6Actimed Therapeut…Acto Technologies Inc. - 10, 19.8ActoAdaptas Solutions PTY Ltd - 10, 15.5Adaptas Solutions…Adaptive Sensory Technology, Inc. - 10, 20.2Adaptive Sensory…Adaptive Tactical LLC - 10, 16.2Adaptive TacticalActivbody, Inc. - 10, 17.7Activbody
Activbody vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Activbody's grants concentrate

Activbody, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 60% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2017. By volume, Activbody sits between Acessa Health Inc. and Adaptive Tactical LLC.

Who files at Activbody's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Activbody holds 10 patents at rank #25,641, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Activbody

By rank, the assignees closest to #25,641 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Activbody's primary technology class.

Activbody's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2017201820192021 2
USPTO utility patent grants by year · 2017–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Activbody, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 10.0%
2018 5 50.0%
2019 2 20.0%
2021 2 20.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Activbody, Inc.'s patent record in context - here's where to go next.

  • Activbody, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 60% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #25,647 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Activbody, Inc. against Acessa Health Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.